Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
about
Type 1 diabetes and osteoporosis: from molecular pathways to bone phenotypeNatural Products from Chinese Medicines with Potential Benefits to Bone HealthEffect of Teriparatide on Healing of Atypical Femoral Fractures: A Systemic ReviewSkeletal complications of bisphosphonate use: what the radiologist should knowDo bisphosphonates cause femoral insufficiency fractures?Incidence and Characteristics of Atypical Femoral Fractures: Clinical and Geometrical Data.MR imaging of the pelvis: a guide to incidental musculoskeletal findings for abdominal radiologists.Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapyA network modeling approach for the spatial distribution and structure of bone mineral contentThe resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronateBisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.Lateral Femoral Bowing and the Location of Atypical Femoral Fractures.Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate.Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis.Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data.Bilateral atypical femoral fractures in a patient with multiple myeloma treated with intravenous bisphosphonate therapy.Effects of LLLT in combination with bisphosphonate on bone healing in critical size defects: a histological and histometric study in rat calvaria.Long term bisphosphonate therapy & atypical femoral fractures: a word of caution.Bisphosphonate drug holidays: Can we recommend currently?Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs.Current perspectives on bisphosphonate treatment in Paget's disease of bone.Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur FracturesThe association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort studyQuestioning the association between bisphosphonates and atypical femoral fracturesUse of oral bisphosphonates in primary prevention of fractures in postmenopausal women: a population-based cohort study.Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjectsLong-term safety concerns of antiresorptive therapy.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Changing pattern of femoral fractures in osteogenesis imperfecta with prolonged use of bisphosphonatesThe effects of zoledronate on the survival and function of human osteoblast-like cellsAtypical femoral fractures: epidemiology, etiology, and patient managementManagement of atypical femoral fracture: a scoping review and comprehensive algorithm.Atypical femur fractures: a review of the evidence and its implication to clinical practiceAre women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.Three years of treatment with minodronate in patients with postmenopausal osteoporosis.Hypophosphatasia and the risk of atypical femur fractures: a case-control study.Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice.Successful conservative treatment: multiple atypical fractures in osteoporotic patients after bisphosphate medication: a unique case reportThe effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT).
P2860
Q21284514-F1EADA33-65F2-43ED-9FE0-16FEE19753BAQ26765485-AA4FDC7B-C829-4675-BFC6-1B992C25F3BDQ26771709-0432F5BD-FBD8-4F60-9466-5CE0C6C22814Q27010157-9F45C597-9D1D-45C2-904D-FA88EDA624ACQ27021396-C5EED9DA-C4A6-47D8-BB03-B461921A6630Q31026858-207C6868-290C-4983-90F5-4F640654B9C8Q33275193-2811A84E-8126-4F5D-8486-7E0C2492CFFFQ33568586-99D3BC7E-9A55-4F77-837C-0EDFA4494CB6Q33574150-A1CC55C9-005F-4E6A-B853-A5543455E851Q33700394-B77D0D00-B028-471E-AD82-307FEE891D46Q33715141-853EBBB1-6398-4169-BF49-0AB3F264AC6DQ33781081-6DD4C685-9782-456E-A5BD-60D86D7855F2Q33822053-40FEEAE4-ECCF-4FA4-B8A6-1BF1A6A6D59AQ33844438-CA1E2994-593B-413B-B42B-CB614C09F679Q33958113-8ED09498-25AE-490A-A6B8-6823081FA22CQ34032539-B7BA3A2A-6C6A-41A2-B4B7-2BD7B65F2653Q34174305-DA806032-671B-4EA0-B79B-8FDF283163BEQ34272165-78C820B7-B61D-4727-AEBB-12DF9144E569Q34329746-2C01086B-1AFD-43E0-B837-8737DB31E215Q34503484-2E226D2C-5DFA-45A7-B23F-4AEE582B5AC2Q34566340-A8E4FF83-4EAA-4BF6-B590-D60C79E353BFQ34626680-F001D755-4CB9-48EB-AB9F-30ADFCF7C47AQ34627029-5A0A59A2-D7AE-407D-8365-FBD1F465042AQ34678657-F3156BFB-CE47-4F55-B7C5-D2F7C0428260Q34899110-3D852E62-D75D-4820-96D4-DD54A2E2AE51Q35364745-AB3994FA-721E-4230-BB03-2CCA39C1CB11Q35566438-73AF7E7A-A0B7-41CF-8017-AC8EEBE3DFD4Q35570961-855492F3-6E51-4AB4-BD43-2D1C1DD7AD24Q35757247-D28BC99B-4971-4AC4-929B-7CB5A1476D08Q35828143-2FADE258-E2AA-4B9C-8E46-3CDA3A282DD8Q35842418-4FDBF1C4-B8A5-43A6-8404-168323E28B5AQ36016579-8538E513-C57A-4B54-AD41-8D7E69042549Q36027214-FBC64AFE-49E8-4866-B0AD-D1A831D71845Q36059445-16AFEA20-57E6-4DE0-93FB-981DF21CB460Q36069758-DC1FEEDF-9C16-4BAF-980C-4E653C6C0F79Q36093829-C05D406C-01F6-4673-8868-2FCBCA4158F7Q36099672-132E48D9-CCE6-448C-9B8C-1CDF553AE4DDQ36125953-B586F9A9-9526-485C-B6C4-40C753C1378EQ36152236-A8A77A2A-943D-4751-8848-0CD0AE7EF267Q36190027-41728083-8788-4DD9-A2E9-108479EF80DC
P2860
Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women
description
article publié dans la revue scientifique Journal of the American Medical Association
@fr
im Februar 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Journal of the American Medical Association
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2011
@uk
name
Bisphosphonate Use and the Ris ...... Shaft Fractures in Older Women
@en
Bisphosphonate Use and the Ris ...... Shaft Fractures in Older Women
@nl
type
label
Bisphosphonate Use and the Ris ...... Shaft Fractures in Older Women
@en
Bisphosphonate Use and the Ris ...... Shaft Fractures in Older Women
@nl
prefLabel
Bisphosphonate Use and the Ris ...... Shaft Fractures in Older Women
@en
Bisphosphonate Use and the Ris ...... Shaft Fractures in Older Women
@nl
P2093
P356
P1476
Bisphosphonate use and the ris ...... shaft fractures in older women
@en
P2093
Andreas Laupacis
Daniel B Whelan
David N Juurlink
Gillian A Hawker
Laura Y Park-Wyllie
Muhammad M Mamdani
Nadia Gunraj
Peter J Weiler
P304
P356
10.1001/JAMA.2011.190
P407
P577
2011-02-01T00:00:00Z